cCARE Partners With Paragon to Offer More Holistic Services
New for patients: cCARE has partnered with Paragon Integrated Health, which offers evidence-based complementary practices, including yoga, nutrition & more.
cCARE Collaborates with Kuppa Joy in Fresno
cCARE adds a stand-alone Kuppa Joy café to the Fresno facility. Kuppa Joy at cCARE provides free coffee concierge services to patients receiving treatment.
cCARE Opens State-of-the-Art Cancer Center in Fresno
cCARE opens new 65,000-square-foot cancer facility to serve the needs of the Fresno and Central Valley community. The cancer center, located at the Saint Agnes Medical Center, is a one-stop-shop for patients.
cCARE Achieves ACHC Accreditation
California Cancer Associates for Research & Excellence achieves accreditation from the Accreditation Commission for Health Care (ACHC). This accreditation reflects our dedication and commitment to meeting standards that facilitate a higher level of performance and patient care.
cCARE Unveils Renderings of Forthcoming Saint Agnes State-of-the-Art Cancer Center
cCARE is preparing to break ground on a fully-funded comprehensive treatment facility on the Saint Agnes Medical Center campus.
cCARE Donates $5,575 for Leukemia & Lymphoma Society at Light the Night
Doctors and staff at cCARE laced up their sneakers and donned glow-in-the-dark garb to walk in support of a cure for blood cancer.
Oncology Group Announces New Fresno Cancer Center
California Cancer Associates for Research and Excellence (cCARE), California’s largest private cancer and hematology group, announces plans to develop 65,000-square-foot cancer center with Saint Agnes Medical Center.
cCARE Launches Refreshed Website
California Cancer Associates for Research and Excellence, cCARE, the largest full-service private oncology practice in California, is pleased to announce the launch of its newly-designed website.
Oncologists: Medicare Proposal Will Limit Cancer Patients’ Access to Drugs, Endanger Chances of Healing
A Medicare proposal for testing new ways to pay for drugs may jeopardize cancer patients’ health and chances of recovery, may also create two unequal classes of patients, and could further result in more patients being forced to seek costlier treatment in hospitals, says one of California’s largest private oncology practices.
cCARE Wins Jury Trial Against Former CEO/President Dr. Michael J. Moffett
A jury in a civil trial in Fresno Superior Court has decided that a local doctor, Michael J. Moffett, should pay more than $1.4 million to California Cancer Associates for Research & Excellence, Inc. (cCARE). cCARE had contended that Moffett misused funds as CEO and attempted to damage cCARE by negotiating a secret deal with a competitive medical practice while still an employee/shareholder.